ClinicalTrials.Veeva

Menu

Study of STIM1 Membrane Expression (STIMEX)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Autoimmune Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT04978948
STIMEX - 29BRC21.0025

Details and patient eligibility

About

The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM.

This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.

Enrollment

670 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of one of the autoimmune diseases

Exclusion criteria

  • Treatment with rituximab in the previous 12 months

Trial design

670 participants in 18 patient groups

Myasthénie
Description:
Blood samples will be collected
Myopathie inflammatoire (Myosite)
Description:
Blood samples will be collected
Neuropathie autoimmune
Description:
Blood samples will be collected
Néphropathies autoimmunes
Description:
Blood samples will be collected
Hépatite auto-immune
Description:
Blood samples will be collected
Pancréatite auto-immune
Description:
Blood samples will be collected
Purpura Thrombopénique Immunologique
Description:
Blood samples will be collected
Dermatose bulleuse
Description:
Blood samples will be collected
Thyroïdite autoimmune
Description:
Blood samples will be collected
Sclérose en plaque
Description:
Blood samples will be collected
Sclérose latérale amyotrophique
Description:
Blood samples will be collected
Polyarthrite Rhumatoïde
Description:
Blood samples will be collected
Spondylarthrite axiale
Description:
Blood samples will be collected
controls
Description:
Patients without autoimune desease\* Blood samples will be collected
Lichen plan buccal auto-immun (LPB)
Description:
Blood samples will be collected
lichen plan buccal allo-immun liée à une GvHD (" Graft versus Host Disease ")
Description:
Blood samples will be collected
Lupus érythémateux systémique
Description:
Blood samples will be collected
Sclérodermie
Description:
Blood samples will be collected

Trial contacts and locations

4

Loading...

Central trial contact

Divi Cornec

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems